How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

BM

NASDAQ:BMEA
Get a brief AI stock analysisSaves ~ 15 minutes of your time

BM

Biomea Fusion IncNASDAQ BMEA Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is BMEA undervalued compared to its fair value?

The fair value of BMEA stock is hidden USD. Relative to the market price of 5.46 USD Biomea Fusion Inc is hidden.

Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company is he...[More about valuation]

Biomea Fusion Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.185 $B

Price:

5.46 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.797

FINANCIALS

Biomea Fusion financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.031 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.028 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.23 B
0.2 B

Financial Position Analysis

Assets

0.23 B
Current Assets
0.2 B
Total non-current assets
0.023 B

Total current liabilities
0.016 B
Total non-current liabilities
0.0093 B

Cash Flow Statement

-0.024 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.024 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Biomea Fusion fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is BMEA attractive for investment based on fundamental analysis?

BMEA stock rating is hidden. Biomea Fusion is a hidden by Eyestock methodology.

Get BMEA Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

BMEA analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for BMEA to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Biomea Fusion Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Biomea Fusion Inc dividends

BMEA dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About BMEA stock

About the company Biomea Fusion Inc

Market cap $B

0.185

Dividend yield

Shares outstanding

29.3962 B

Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company is headquartered in Redwood City, California and currently employs 51 full-time employees. The company went IPO on 2021-04-16. The firm is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The firm has built FUSION System discovery platform to advance a pipeline of irreversible small molecule product candidates. The firm's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. The firm is developing BMF-219 for the treatment of liquid and solid tumors that are dependent on menin, including leukemias containing the mixed lineage leukemia (MLL) fusion protein. The firm is also advancing other preclinical irreversible programs for the treatment of select cancers.

BMEA profile

  • Ticker

    BMEA

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    16 April 2021

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    51

  • City

    Redwood City

  • Address

    900 Middlefield Road, 4Th Floor

  • Cusip

    09077A106